“An Audit to Evaluate the Clinical Safety and PSA Response of Firmagon® (Degarelix) in Patients With Advanced Metastatic Prostate Cancer -”. Journal of Cancer Research Updates 2, no. 1 (January 14, 2013):  21–25. Accessed May 9, 2026. https://www.neoplasiaresearch.com/index.php/jcru/article/view/398.